Chronic Migraine Treatment Market, Global Outlook and Forecast 2022-2028

March 2022 | 67 pages | ID: C122614ED00EEN
Market Monitor Global

Abstracts

Migraine is a painful, episodic disease that sometimes develops into a chronic condition. It is one of the most common neurological diseases in clinical practice. Chronic migraines (CM) are a natural progression of chronic migraines, with a frequency of 15 days per month and similar characteristics to migraine attacks.

This report contains market size and forecasts of Chronic Migraine Treatment in Global, including the following market information:

Global Chronic Migraine Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Chronic Migraine Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Drug Treatment Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Chronic Migraine Treatment include Novartis, Pfizer, AstraZeneca, Allergan, GlaxoSmithKline, Eli Lilly, Merck, Johnson&Johnson and Zosano and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Chronic Migraine Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Chronic Migraine Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Chronic Migraine Treatment Market Segment Percentages, by Type, 2021 (%)

• Drug Treatment
• Substitution Treatment

Global Chronic Migraine Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Chronic Migraine Treatment Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Clinics
• Others

Global Chronic Migraine Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Chronic Migraine Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Chronic Migraine Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Chronic Migraine Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Novartis
• Pfizer
• AstraZeneca
• Allergan
• GlaxoSmithKline
• Eli Lilly
• Merck
• Johnson&Johnson
• Zosano
• Alder BioPharmaceuticals

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Chronic Migraine Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Chronic Migraine Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL CHRONIC MIGRAINE TREATMENT OVERALL MARKET SIZE

2.1 Global Chronic Migraine Treatment Market Size: 2021 VS 2028
2.2 Global Chronic Migraine Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Chronic Migraine Treatment Players in Global Market
3.2 Top Global Chronic Migraine Treatment Companies Ranked by Revenue
3.3 Global Chronic Migraine Treatment Revenue by Companies
3.4 Top 3 and Top 5 Chronic Migraine Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Chronic Migraine Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Chronic Migraine Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Chronic Migraine Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Chronic Migraine Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Chronic Migraine Treatment Market Size Markets, 2021 & 2028
  4.1.2 Drug Treatment
  4.1.3 Substitution Treatment
4.2 By Type - Global Chronic Migraine Treatment Revenue & Forecasts
  4.2.1 By Type - Global Chronic Migraine Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Chronic Migraine Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Chronic Migraine Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Chronic Migraine Treatment Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Clinics
  5.1.4 Others
5.2 By Application - Global Chronic Migraine Treatment Revenue & Forecasts
  5.2.1 By Application - Global Chronic Migraine Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Chronic Migraine Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Chronic Migraine Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Chronic Migraine Treatment Market Size, 2021 & 2028
6.2 By Region - Global Chronic Migraine Treatment Revenue & Forecasts
  6.2.1 By Region - Global Chronic Migraine Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Chronic Migraine Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Chronic Migraine Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Chronic Migraine Treatment Revenue, 2017-2028
  6.3.2 US Chronic Migraine Treatment Market Size, 2017-2028
  6.3.3 Canada Chronic Migraine Treatment Market Size, 2017-2028
  6.3.4 Mexico Chronic Migraine Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Chronic Migraine Treatment Revenue, 2017-2028
  6.4.2 Germany Chronic Migraine Treatment Market Size, 2017-2028
  6.4.3 France Chronic Migraine Treatment Market Size, 2017-2028
  6.4.4 U.K. Chronic Migraine Treatment Market Size, 2017-2028
  6.4.5 Italy Chronic Migraine Treatment Market Size, 2017-2028
  6.4.6 Russia Chronic Migraine Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Chronic Migraine Treatment Market Size, 2017-2028
  6.4.8 Benelux Chronic Migraine Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Chronic Migraine Treatment Revenue, 2017-2028
  6.5.2 China Chronic Migraine Treatment Market Size, 2017-2028
  6.5.3 Japan Chronic Migraine Treatment Market Size, 2017-2028
  6.5.4 South Korea Chronic Migraine Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Chronic Migraine Treatment Market Size, 2017-2028
  6.5.6 India Chronic Migraine Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Chronic Migraine Treatment Revenue, 2017-2028
  6.6.2 Brazil Chronic Migraine Treatment Market Size, 2017-2028
  6.6.3 Argentina Chronic Migraine Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Chronic Migraine Treatment Revenue, 2017-2028
  6.7.2 Turkey Chronic Migraine Treatment Market Size, 2017-2028
  6.7.3 Israel Chronic Migraine Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Chronic Migraine Treatment Market Size, 2017-2028
  6.7.5 UAE Chronic Migraine Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Novartis
  7.1.1 Novartis Corporate Summary
  7.1.2 Novartis Business Overview
  7.1.3 Novartis Chronic Migraine Treatment Major Product Offerings
  7.1.4 Novartis Chronic Migraine Treatment Revenue in Global Market (2017-2022)
  7.1.5 Novartis Key News
7.2 Pfizer
  7.2.1 Pfizer Corporate Summary
  7.2.2 Pfizer Business Overview
  7.2.3 Pfizer Chronic Migraine Treatment Major Product Offerings
  7.2.4 Pfizer Chronic Migraine Treatment Revenue in Global Market (2017-2022)
  7.2.5 Pfizer Key News
7.3 AstraZeneca
  7.3.1 AstraZeneca Corporate Summary
  7.3.2 AstraZeneca Business Overview
  7.3.3 AstraZeneca Chronic Migraine Treatment Major Product Offerings
  7.3.4 AstraZeneca Chronic Migraine Treatment Revenue in Global Market (2017-2022)
  7.3.5 AstraZeneca Key News
7.4 Allergan
  7.4.1 Allergan Corporate Summary
  7.4.2 Allergan Business Overview
  7.4.3 Allergan Chronic Migraine Treatment Major Product Offerings
  7.4.4 Allergan Chronic Migraine Treatment Revenue in Global Market (2017-2022)
  7.4.5 Allergan Key News
7.5 GlaxoSmithKline
  7.5.1 GlaxoSmithKline Corporate Summary
  7.5.2 GlaxoSmithKline Business Overview
  7.5.3 GlaxoSmithKline Chronic Migraine Treatment Major Product Offerings
  7.5.4 GlaxoSmithKline Chronic Migraine Treatment Revenue in Global Market (2017-2022)
  7.5.5 GlaxoSmithKline Key News
7.6 Eli Lilly
  7.6.1 Eli Lilly Corporate Summary
  7.6.2 Eli Lilly Business Overview
  7.6.3 Eli Lilly Chronic Migraine Treatment Major Product Offerings
  7.6.4 Eli Lilly Chronic Migraine Treatment Revenue in Global Market (2017-2022)
  7.6.5 Eli Lilly Key News
7.7 Merck
  7.7.1 Merck Corporate Summary
  7.7.2 Merck Business Overview
  7.7.3 Merck Chronic Migraine Treatment Major Product Offerings
  7.7.4 Merck Chronic Migraine Treatment Revenue in Global Market (2017-2022)
  7.7.5 Merck Key News
7.8 Johnson&Johnson
  7.8.1 Johnson&Johnson Corporate Summary
  7.8.2 Johnson&Johnson Business Overview
  7.8.3 Johnson&Johnson Chronic Migraine Treatment Major Product Offerings
  7.8.4 Johnson&Johnson Chronic Migraine Treatment Revenue in Global Market (2017-2022)
  7.8.5 Johnson&Johnson Key News
7.9 Zosano
  7.9.1 Zosano Corporate Summary
  7.9.2 Zosano Business Overview
  7.9.3 Zosano Chronic Migraine Treatment Major Product Offerings
  7.9.4 Zosano Chronic Migraine Treatment Revenue in Global Market (2017-2022)
  7.9.5 Zosano Key News
7.10 Alder BioPharmaceuticals
  7.10.1 Alder BioPharmaceuticals Corporate Summary
  7.10.2 Alder BioPharmaceuticals Business Overview
  7.10.3 Alder BioPharmaceuticals Chronic Migraine Treatment Major Product Offerings
  7.10.4 Alder BioPharmaceuticals Chronic Migraine Treatment Revenue in Global Market (2017-2022)
  7.10.5 Alder BioPharmaceuticals Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Chronic Migraine Treatment Market Opportunities & Trends in Global Market
Table 2. Chronic Migraine Treatment Market Drivers in Global Market
Table 3. Chronic Migraine Treatment Market Restraints in Global Market
Table 4. Key Players of Chronic Migraine Treatment in Global Market
Table 5. Top Chronic Migraine Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Chronic Migraine Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Chronic Migraine Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Chronic Migraine Treatment Product Type
Table 9. List of Global Tier 1 Chronic Migraine Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Chronic Migraine Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Chronic Migraine Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Chronic Migraine Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Chronic Migraine Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Chronic Migraine Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Chronic Migraine Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Chronic Migraine Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Chronic Migraine Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Chronic Migraine Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Chronic Migraine Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Chronic Migraine Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Chronic Migraine Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Chronic Migraine Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Chronic Migraine Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Chronic Migraine Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Chronic Migraine Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Chronic Migraine Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Chronic Migraine Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Chronic Migraine Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Chronic Migraine Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Novartis Corporate Summary
Table 31. Novartis Chronic Migraine Treatment Product Offerings
Table 32. Novartis Chronic Migraine Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Pfizer Corporate Summary
Table 34. Pfizer Chronic Migraine Treatment Product Offerings
Table 35. Pfizer Chronic Migraine Treatment Revenue (US$, Mn), (2017-2022)
Table 36. AstraZeneca Corporate Summary
Table 37. AstraZeneca Chronic Migraine Treatment Product Offerings
Table 38. AstraZeneca Chronic Migraine Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Allergan Corporate Summary
Table 40. Allergan Chronic Migraine Treatment Product Offerings
Table 41. Allergan Chronic Migraine Treatment Revenue (US$, Mn), (2017-2022)
Table 42. GlaxoSmithKline Corporate Summary
Table 43. GlaxoSmithKline Chronic Migraine Treatment Product Offerings
Table 44. GlaxoSmithKline Chronic Migraine Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Eli Lilly Corporate Summary
Table 46. Eli Lilly Chronic Migraine Treatment Product Offerings
Table 47. Eli Lilly Chronic Migraine Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Merck Corporate Summary
Table 49. Merck Chronic Migraine Treatment Product Offerings
Table 50. Merck Chronic Migraine Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Johnson&Johnson Corporate Summary
Table 52. Johnson&Johnson Chronic Migraine Treatment Product Offerings
Table 53. Johnson&Johnson Chronic Migraine Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Zosano Corporate Summary
Table 55. Zosano Chronic Migraine Treatment Product Offerings
Table 56. Zosano Chronic Migraine Treatment Revenue (US$, Mn), (2017-2022)
Table 57. Alder BioPharmaceuticals Corporate Summary
Table 58. Alder BioPharmaceuticals Chronic Migraine Treatment Product Offerings
Table 59. Alder BioPharmaceuticals Chronic Migraine Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Chronic Migraine Treatment Segment by Type in 2021
Figure 2. Chronic Migraine Treatment Segment by Application in 2021
Figure 3. Global Chronic Migraine Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Chronic Migraine Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Chronic Migraine Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Chronic Migraine Treatment Revenue in 2021
Figure 8. By Type - Global Chronic Migraine Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Chronic Migraine Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Chronic Migraine Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Chronic Migraine Treatment Revenue Market Share, 2017-2028
Figure 12. US Chronic Migraine Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Chronic Migraine Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Chronic Migraine Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Chronic Migraine Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Chronic Migraine Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Chronic Migraine Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Chronic Migraine Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Chronic Migraine Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Chronic Migraine Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Chronic Migraine Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Chronic Migraine Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Chronic Migraine Treatment Revenue Market Share, 2017-2028
Figure 24. China Chronic Migraine Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Chronic Migraine Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Chronic Migraine Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Chronic Migraine Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Chronic Migraine Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Chronic Migraine Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Chronic Migraine Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Chronic Migraine Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Chronic Migraine Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Chronic Migraine Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Chronic Migraine Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Chronic Migraine Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Chronic Migraine Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Novartis Chronic Migraine Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Pfizer Chronic Migraine Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. AstraZeneca Chronic Migraine Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Allergan Chronic Migraine Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. GlaxoSmithKline Chronic Migraine Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Eli Lilly Chronic Migraine Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Merck Chronic Migraine Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Johnson&Johnson Chronic Migraine Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Zosano Chronic Migraine Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Alder BioPharmaceuticals Chronic Migraine Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)